FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper

Affiliations

• ¹ University of Cincinnati Cancer Institute, Dept. of Ob/Gyn, University of Cincinnati, United States.
• ² Office of Hematology Oncology Products, OND, CDER, FDA, United States.
• ³ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, United States.
• ⁴ Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States.
• ⁵ Ovarian Cancer Survivor, White Plains, New York.
• ⁶ Division of Biometrics V, OB, OTS, CDER, FDA, United States.
• ⁷ Ovarian Cancer Alliance of San Diego, United States.
• ⁸ U.S. Oncology, Phoenix, AZ, United States.
• ⁹ Oncology Center of Excellence, OMPT, FDA, United States.
• ¹⁰ Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: rcoleman@mdanderson.org.